搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
precisionmedicineonline
4 天
Is There a Role for Precision Medicine With GLP-1 Drugs?
As the popularity of drugs like Ozempic and Mounjaro soar, researchers, doctors, biotechs, and diagnostic firms see a role ...
precisionmedicineonline
9 天
BRCA1/2 Mutations Aren't Equal: Researchers Push for Reduced Penetrance Pathogenic Variant ...
Researchers worked with two labs to identify 16 consensus lower-risk pathogenic variants and are pushing for greater ...
precisionmedicineonline
4 天
Mayo Clinic Studying Use of Neurofilament as Biomarker to Guide Treatment of ALS Patients
In a first-of-its-kind trial, physicians will review neurofilament test results with patients and decide whether to continue ...
precisionmedicineonline
2 天
MUSC Hollings Cancer Center Researchers Launch AI-Driven Precision Oncology Initiative
Hollings researchers will develop AI-driven tools to better match cancer patients to marketed therapies and clinical trials.
precisionmedicineonline
2 天
PolTreg Gearing Up for Treg Cell Therapy Trial in Children With Presymptomatic Diabetes
The firm is also studying PTG-007 in patients with early-stage type 1 diabetes, but is looking for a partner for the pivotal trial.
precisionmedicineonline
5 天
AstraZeneca Partners With Lunit to Develop AI-Driven Biomarker Prediction Tools
The firms will initially develop a tool to identify NSCLC patients with EGFR mutations who can benefit from targeted therapy.
precisionmedicineonline
11 天
McKesson Bets on Cell, Gene Therapy Products as it Corrals Services in New Business Unit
The pharmaceutical distributor has launched InspiroGene, a business unit offering logistics and other support for ...
precisionmedicineonline
10 天
After Success in Treating Cancer, CAR T Cells Break Into Autoimmune, HIV, and More
As drugmakers take lessons from oncology in developing CAR T cells for other diseases, they must contend with risks that ...
precisionmedicineonline
3 天
Novartis Acquires Kate Therapeutics in $1.1B Deal
NEW YORK – Novartis on Thursday announced it has acquired Kate Therapeutics to bolster its capabilities to develop gene therapies for inherited neuromuscular diseases. In the transaction valued at ...
precisionmedicineonline
3 天
Aptose Launches Phase I/II Study of FLT3 Inhibitor in Newly Diagnosed AML
The firm will track the activity of the triplet broadly in AML patients, including in those with FLT3, NRAS, and TP53 mutations.
precisionmedicineonline
11 天
Genetic Testing Challenges in Precision Medicine: Li-Fraumeni Diagnosis Missed in Young Patient
A 31-year-old woman with stage IV breast cancer learns a test ordered more than a year before her diagnosis detected a TP53 ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈